Key Takeaways IRTC's AMALFI trial found Zio monitoring improved AF detection and shortened diagnosis time.The study enrolled 5,040 participants across 27 UK practices, fully remote and randomized.Zio users had 26% higher AF detection and faster access to anticoagulation treatment. iRhythm Technologies, Inc. (IRTC) recently published the results from the Oxford University-led Active Monitoring for AtriaL FIbrillation (AMALFI) randomized clinical trial. The study showed that home-based screening with the comp ...